首页> 外国专利> USE OF COMPOUNDS OF THE RETULINE SERIES AS COMPOUNDS WITH PHARMACEUTICAL ACTIVITY, IN PARTICULAR ANALGESIC, ANTISPASMODIC AND ANTIINFLAMMATORY MEDICAMENTS

USE OF COMPOUNDS OF THE RETULINE SERIES AS COMPOUNDS WITH PHARMACEUTICAL ACTIVITY, IN PARTICULAR ANALGESIC, ANTISPASMODIC AND ANTIINFLAMMATORY MEDICAMENTS

机译:将RETULINE系列化合物用作具有药理活性的化合物,用于特定的止痛药,抗炎药和抗炎药

摘要

Compounds with pharmaceutical activity having general formula (I), where in position 16, either R1 or R2 is hydrogen, while the substituent R1 or R2 which is not hydrogen is -CH2OH- or acylated, preferably acylated, -CH2OH-, or an aldehyde function; R3 in position 1 is an alkyl or acyl residue, preferably an acetylated residue, R4 in position 18 is an alkyl, preferably methyl, chain, a -CH2OH- group or an acylated, preferably acetylated, -CH2OH- group; R5 is hydrogen or a substituent on the benzene ring which can be hydroxyl or methoxy. Also described are the substituted compounds on the nitrogen in position 4 and the derivatives in which the C19-C20 double bond is hydrogenated. The compounds have an anti-inflammatory analgesic and antispasmodic effect.
机译:具有通式(I)的具有药物活性的化合物,其中在16位上,R1或R2为氢,而非氢的取代基R1或R2为-CH2OH-或酰化,优选为酰化的-CH2OH-或醛功能;在位置1上的R3是烷基或酰基残基,优选为乙酰化的残基,在位置18上的R4是烷基,优选为甲基,-CH2OH-基团或酰化的,优选为乙酰化的-CH2OH-基团; R 5是氢或苯环上的取代基,可以是羟基或甲氧基。还描述了在4位氮上的取代的化合物和其中C19-C20双键被氢化的衍生物。该化合物具有消炎镇痛和解痉作用。

著录项

  • 公开/公告号AU2790189A

    专利类型

  • 公开/公告日1989-07-05

    原文格式PDF

  • 申请/专利权人 UNIVERSITE DE LIEGE;

    申请/专利号AU19890027901

  • 发明设计人 LUC ANGENOT;JACQUES DAMAS;MONIQUE TITS;

    申请日1989-11-24

  • 分类号C07D471/20;A61K31/435;

  • 国家 AU

  • 入库时间 2022-08-22 06:35:57

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号